Did a conflict over intellectual property delay the Ebola vaccine?
Friday, October 3, 2014: A CBC headline read, “Could Ebola vaccine delay be due to an intellectual property spat?” By the next morning a colleague, Richard Gold of McGill, and I had figured out that the “IP” (intellectual property) was in fact a non-story. Whatever was delaying the start of a research trial to test …


















